Allotment- Update

Axis Bank Limited
30 June 2026
 

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL

 

AXIS/CO/CS/211/2026-27

 

June 30, 2026

 

National Stock Exchange of India Limited

Exchange Plaza,

Plot No. C/1, "G" Block

Bandra-Kurla Complex

Bandra (E), Mumbai - 400 051

 

NSE Symbol: AXISBANK

BSE Limited

P. J. Towers,

Dalal Street

Fort, Mumbai - 400 001

 

 

BSE Scrip Code: 532215

 

Dear Sir/Madam,

 

Sub.: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended 

 

In furtherance to our letters bearing reference numbers AXIS/CO/CS/493/2025-26 dated December 26, 2025 and AXIS/CO/CS/181/2026-27 dated June 23, 2026, we wish to inform you that Axis Bank Limited has successfully allotted US$500,000,000 6.875% Additional Tier 1 Notes and US$300,000,000 5.348% Senior Notes, in each case under its US$5,000,000,000 Global Medium Term Note Programme (collectively referred to as the "Notes"). The issuance and allotment of the Notes have been completed in accordance with the applicable laws and regulatory requirements.

 

The Notes will be listed on Global Securities Market of the India International Exchange (IFSC) Limited and Debt Securities Market of the NSE IFSC Limited.

 

This is for information of all concerned in compliance with the applicable provisions of the Listing Regulations.

 

 

Thanking you,

 

Yours faithfully,

For Axis Bank Limited

 

 

Sandeep Poddar

Company Secretary

 

CC: London Stock Exchange

        Singapore Stock Exchange

 

DISCLAIMER:

The offering circular dated December 26, 2025 ("Offering Circular")  and pricing supplements for the GMTN Programme have not been and will not be registered or filed or published as a prospectus or a statement in lieu of a prospectus with the Securities and Exchange Board of India, the relevant Registrar of Companies, or any other statutory or regulatory body of like nature in India in respect of a public offer or information memorandum, general information document, key information document or other offering material in respect of any private placement of securities under the Companies Act, 2013, as amended, and the rules thereunder or any other applicable Indian laws.

 

The Offering Circular and pricing supplements have not been and will not be reviewed or approved by any regulatory authority in India, including, but not limited to, the relevant Registrar of Companies, the Securities and Exchange Board of India, the Reserve Bank of India, or any recognised stock exchange in India. The Offering Circular is not and should not be construed as an advertisement, invitation, offer or sale of any securities to the public or any person resident in India.

 

The Notes have not been and will not be, offered or sold to any person resident in India.

The Notes have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any state of the United States or any other jurisdiction and the Notes may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state or local securities laws.

 
http://www.rns-pdf.londonstockexchange.com/rns/4536K_1-2026-6-30.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings